The most common somatic pathogenic variant in the exon 14, p.Val617Phe, which is responsible for the development of PV and other MPNs, allows the kinase to evade negative regulation and confer constitutive activation of JAK2 (Gnanasambandan and Sayeski, 2011). This evidence concerns the gene JAK2 and acquired polycythemia vera.